Humana (HUM) Stock Price, News & Analysis

$316.04
-11.94 (-3.64%)
(As of 04/24/2024 ET)
Today's Range
$309.23
$336.00
50-Day Range
$304.33
$351.58
52-Week Range
$299.23
$541.21
Volume
3.49 million shs
Average Volume
2.01 million shs
Market Capitalization
$38.13 billion
P/E Ratio
15.95
Dividend Yield
1.12%
Price Target
$454.63

Humana MarketRank™ Stock Analysis

Analyst Rating
Hold
2.47 Rating Score
Upside/​Downside
43.9% Upside
$454.63 Price Target
Short Interest
Healthy
2.04% of Float Sold Short
Dividend Strength
Strong
Based on Four Factors
Sustainability
-0.75
Upright™ Environmental Score
News Sentiment
0.40mentions of Humana in the last 14 days
Based on 43 Articles This Week
Insider Trading
Acquiring Shares
$200,064 Bought Last Quarter
Proj. Earnings Growth
42.34%
From $16.06 to $22.86 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

5.00 out of 5 stars

Medical Sector

2nd out of 909 stocks

Hospital & Medical Service Plans Industry

1st out of 11 stocks

HUM stock logo

About Humana Stock (NYSE:HUM)

Humana Inc., together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, life insurance, and other supplemental health benefits, as well as administrative services only products to individuals and employer groups; military services, such as TRICARE T2017 East Region contract; and engages in the operations of pharmacy benefit manager business. Further, it operates pharmacies and senior focused primary care centers; and offers home solutions services, such as home health, hospice, and other services to its health plan members, as well as to third parties. The company sells its products through employers and employees, independent brokers and agents, sales representatives, and digital insurance agencies. The company was formerly known as Extendicare Inc. and changed its name to Humana Inc. in April 1974. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.

HUM Stock Price History

HUM Stock News Headlines

Exposed: 10 CENT Crypto to Explode April 20th?
Former Wall Street Insider and Professional Money Manager Reveals 4 Cryptos BETTER Than Bitcoin
Exposed: 10 CENT Crypto to Explode April 20th?
Former Wall Street Insider and Professional Money Manager Reveals 4 Cryptos BETTER Than Bitcoin
Humana earnings preview: what Wall Street is expecting
Humana (NYSE:HUM) PT Lowered to $381.00
Humana (NYSE:HUM) Is Due To Pay A Dividend Of $0.885
The political life and lessons of George Atkins
Humana (NYSE:HUM) Shares Gap Up to $314.64
Smart Money Is Betting Big In HUM Options
Humana (HUM) Set to Announce Quarterly Earnings on Wednesday
Wells Fargo Keeps Their Buy Rating on Humana (HUM)
See More Headlines
Receive HUM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Humana and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 1/26 Dividend
12/28/2023
Dividend Payable
1/26/2024
Ex-Dividend for 4/26 Dividend
3/27/2024
Today
4/24/2024
Last Earnings
4/24/2024
Next Earnings (Confirmed)
4/24/2024
Dividend Payable
4/26/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Hospital & medical service plans
Sub-Industry
Managed Health Care
CUSIP
44485910
Employees
67,600
Year Founded
1961

Price Target and Rating

Average Stock Price Target
$454.63
High Stock Price Target
$630.00
Low Stock Price Target
$310.00
Potential Upside/Downside
+43.9%
Consensus Rating
Hold
Rating Score (0-4)
2.47
Research Coverage
19 Analysts

Profitability

Net Income
$2.49 billion
Pretax Margin
3.18%

Debt

Sales & Book Value

Annual Sales
$106.37 billion
Cash Flow
$33.30 per share
Book Value
$132.55 per share

Miscellaneous

Free Float
120,303,000
Market Cap
$38.13 billion
Optionable
Optionable
Beta
0.45

Social Links

Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Should I Buy Humana Stock? HUM Pros and Cons Explained

Pros

Here are some ways that investors could benefit from investing in Humana Inc.:

  • Humana's strong quarterly revenue growth of 17.9% year-over-year indicates a positive trend in the company's financial performance.
  • Humana's return on equity of 19.44% showcases the company's ability to generate profits from shareholders' investments.
  • Humana's consistent dividend payments, with a current annualized dividend of $3.54 and a yield of 1.01%, provide investors with a steady income stream.
  • Insider buying activity, such as Director Jorge S. Mesquita purchasing shares at an average price of $367.09, can signal confidence in the company's future prospects.
  • Positive analyst ratings and target prices suggest a favorable outlook for Humana's stock performance in the market.

Cons

Investors should be bearish about investing in Humana Inc. for these reasons:

  • Humana's payout ratio of 17.86% indicates a significant portion of earnings being distributed as dividends, potentially limiting reinvestment for growth.
  • Analyst downgrades, such as Argus lowering Humana from a "buy" to a "hold" rating, may reflect concerns about the company's future performance.
  • Market volatility and regulatory changes in the healthcare industry could impact Humana's operations and financial results unpredictably.
  • Competitive pressures from other healthcare providers and insurers may challenge Humana's market position and profitability in the long term.
  • Uncertainties surrounding healthcare policies and government regulations could introduce risks to Humana's business model and profitability.
These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Wednesday, April 10, 2024. Please send any questions or comments about these Humana pros and cons to contact@marketbeat.com.

HUM Stock Analysis - Frequently Asked Questions

Should I buy or sell Humana stock right now?

19 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Humana in the last year. There are currently 10 hold ratings and 9 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" HUM shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in HUM, but not buy additional shares or sell existing shares.
View HUM analyst ratings
or view top-rated stocks.

What is Humana's stock price target for 2024?

19 Wall Street analysts have issued 12-month target prices for Humana's shares. Their HUM share price targets range from $310.00 to $630.00. On average, they expect the company's share price to reach $454.63 in the next year. This suggests a possible upside of 43.9% from the stock's current price.
View analysts price targets for HUM
or view top-rated stocks among Wall Street analysts.

How have HUM shares performed in 2024?

Humana's stock was trading at $457.81 at the start of the year. Since then, HUM shares have decreased by 31.0% and is now trading at $316.04.
View the best growth stocks for 2024 here
.

Are investors shorting Humana?

Humana saw a increase in short interest in March. As of March 15th, there was short interest totaling 2,570,000 shares, an increase of 14.7% from the February 29th total of 2,240,000 shares. Based on an average daily volume of 1,940,000 shares, the short-interest ratio is currently 1.3 days. Currently, 2.1% of the company's shares are sold short.
View Humana's Short Interest
.

When is Humana's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, April 24th 2024.
View our HUM earnings forecast
.

How were Humana's earnings last quarter?

Humana Inc. (NYSE:HUM) released its quarterly earnings data on Wednesday, April, 24th. The insurance provider reported $7.23 earnings per share for the quarter, beating analysts' consensus estimates of $6.12 by $1.11. The insurance provider earned $29.61 billion during the quarter, compared to analysts' expectations of $28.52 billion. Humana had a net margin of 2.34% and a trailing twelve-month return on equity of 19.44%. The business's quarterly revenue was up 10.7% compared to the same quarter last year. During the same period in the previous year, the firm posted $9.38 earnings per share.

How often does Humana pay dividends? What is the dividend yield for Humana?

Humana announced a quarterly dividend on Thursday, April 18th. Shareholders of record on Friday, June 28th will be paid a dividend of $0.885 per share on Friday, July 26th. This represents a $3.54 dividend on an annualized basis and a yield of 1.12%. The ex-dividend date of this dividend is Friday, June 28th.
Read our dividend analysis for HUM
.

Is Humana a good dividend stock?

Humana (NYSE:HUM) pays an annual dividend of $3.54 per share and currently has a dividend yield of 1.09%. The company has been increasing its dividend for 7 consecutive years, indicating the company has a new, but growing committment to grow its dividend. The dividend payout ratio is 17.86%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, HUM will have a dividend payout ratio of 15.49% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for HUM.

What guidance has Humana issued on next quarter's earnings?

Humana updated its FY24 earnings guidance on Wednesday, April, 24th. The company provided earnings per share guidance of approx. $16.00 for the period, compared to the consensus earnings per share estimate of $16.35.

What is Bruce D. Broussard's approval rating as Humana's CEO?

1,597 employees have rated Humana Chief Executive Officer Bruce D. Broussard on Glassdoor.com. Bruce D. Broussard has an approval rating of 87% among the company's employees.

What other stocks do shareholders of Humana own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Humana investors own include UnitedHealth Group (UNH), NVIDIA (NVDA), Walt Disney (DIS), Visa (V), Mastercard (MA), Alibaba Group (BABA), Boeing (BA), Salesforce (CRM), Johnson & Johnson (JNJ) and JPMorgan Chase & Co. (JPM).

Who are Humana's major shareholders?

Humana's stock is owned by a variety of retail and institutional investors. Top institutional investors include Allspring Global Investments Holdings LLC (0.51%), Sumitomo Mitsui Trust Holdings Inc. (0.28%), Perpetual Ltd (0.09%), Raymond James & Associates (0.08%), State of Michigan Retirement System (0.03%) and Leeward Investments LLC MA (0.02%). Insiders that own company stock include Bruce D Broussard, Christopher H Hunter, David A Jr/Ky Jones, Jorge S Mesquita, Joseph C Ventura, Samir Deshpande, Susan M Diamond, Timothy Alan Wheatley, Timothy S Huval and William Kevin Fleming.
View institutional ownership trends
.

How do I buy shares of Humana?

Shares of HUM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Does Humana have any subsidiaries?
The following companies are subsidiares of Humana: 154th Street Medical Plaza, 516-526 West Main Street Condominium Council of Co-Owners, 54th Street Medical Plaza, American Eldercare, American Eldercare of North Florida, Anvita Health, Arcadian Health Plan, Arcadian Management Services, Atlantis Physician Group, CAC Medical Center Holdings, CAC-Florida Medical Centers, CDO 1, CDO 2, CHA HMO, CHA Service Company, Care Partners Home Care, CareNetwork, CarePlus Health, CarePlus Health Plans, Cariten Health Plan Inc., Certify Data Systems, CompBenefits, CompBenefits Company, CompBenefits Corporation, CompBenefits Dental, CompBenefits Direct, CompBenefits Insurance Company, Complex Clinical Management, Concentra Managed Care, Continucare Corporation, Continucare MDHC, Continucare MSO, Continucare Medical Management, Dental Care Plus Management, DentiCare, Emphesys, Emphesys Insurance Company, Enclara Healthcare, FPG, FPG Acquisition Corp., FPG Acquisition Holdings Corp., FPG Senior Services, Family Physicians of Winter Park, Go365, HUM Provider Holdings, HUM-e-FL, Harris Rothenberg International, Health Value Management, Humana Active Outlook, Humana At Home (Dallas), Humana At Home (Houston), Humana At Home (San Antonio), Humana At Home (TLC), Humana At Home 1, Humana Behavioral Health, Humana Benefit Plan of Illinois, Humana Dental Company, Humana Digital Health and Analytics Platform Services, Humana EAP and Work-Life Services of California, Humana Employers Health Plan of Georgia, Humana Government Business, Humana Health Benefit Plan of Louisiana, Humana Health Company of New York, Humana Health Insurance Company of Florida, Humana Health Plan, Humana Health Plan of California, Humana Health Plan of Ohio, Humana Health Plan of Texas, Humana Health Plans of Puerto Rico, Humana Healthcare Research, Humana Inc., Humana Innovation Enterprises, Humana Insurance Company, Humana Insurance Company of Kentucky, Humana Insurance Company of New York, Humana Insurance of Puerto Rico, Humana Management Services of Puerto Rico, Humana MarketPOINT, Humana MarketPOINT of Puerto Rico, Humana Medical Plan, Humana Medical Plan of Michigan, Humana Medical Plan of Pennsylvania, Humana Medical Plan of Utah, Humana Pharmacy, Humana Pharmacy Solutions, Humana Regional Health Plan, Humana Veterans Healthcare Services, Humana WellWorks LLC, Humana Wisconsin Health Organization Insurance Corporation, Humana at Home, HumanaDental, HumanaDental Insurance Company, Humco, Hummingbird Coaching Systems LLC, Independent Care Health Plan, KMG America, Kindred Healthcare, MCCI Group Holdings, MCCI Holdings, MCCI Medical Group, MCCI Specialty, MCCI/Lifetime of Aventura, MD Care, METCARE of Florida, Managed Care Indemnity, Medical Care Consortium Incorporated of Texas, MetCare, Metropolitan Health Networks, Naples Health Care Specialists, North Region Providers, Nursing Solutions, OSF HealthCare, PHP Companies, Partners in Integrated Care, Preferred Health Partnership, Preservation on Main, Primary Care Holdings, Primary Care Holdings II, Primary Care Specialists of the Palm Beaches, RMA Medical Centers of Florida, RMA Medical Group of Florida, ROHC, SeniorBridge, SeniorBridge Family Companies (CT), SeniorBridge Family Companies (FL), SeniorBridge Family Companies (IN), SeniorBridge Family Companies (MO), SeniorBridge Family Companies (NY), SeniorBridge-Florida, Texas Dental Plans, The Dental Concern, Transcend Population Health Management, and Transcend Population Health Management II.
Read More
This page (NYSE:HUM) was last updated on 4/24/2024 by MarketBeat.com Staff

From Our Partners